This educational activity is designed to help learners better understand the history of developmental and epileptic encephalopathies (DEEs), utilize genetic evaluation for patients with DEEs, and review best practices for managing the comprehensive burdens of DEEs.

RELEASED DATE: October 31, 2024
EXPIRATION DATE: November 27, 2025

Welcome to an enlightening enduring activity dedicated to elevating the knowledge and skill set of cardiologists in managing patients with idiopathic hypersomnia (IH) and narcolepsy. As vital members of the multidisciplinary team (MDT), cardiologists play a crucial role in addressing the unique challenges presented by these sleep disorders. This symposium specifically aims to enrich your understanding of the cardiovascular risks associated with IH and narcolepsy, empowering you to implement evidence-based treatment strategies that prioritize patient safety and well-being.

The education will seek to help HCPs better assess the burden of IH and narcolepsy, including the major cardiovascular risks comorbid with IH and narcolepsy; summarize the importance of limiting sodium intake to manage cardiovascular risk in patients with IH and narcolepsy, including through use of lower-sodium oxybate; and justify the importance of a multidisciplinary shared decision-making approach in patients with IH and narcolepsy to ensure optimal clinical management.

RELEASED DATE: December 03, 2024
EXPIRATION DATE: December 03, 2025

This unique educational program is designed to increase the target audience’s ability to provide a timely and accurate DEE diagnosis, utilize evidence-based, multidisciplinary best practices for disease management, and empower patients with DEEs and their caregivers to actively participate in the treatment journey which will improve the pediatric-to-adult transition of care and long-term outcomes.

RELEASED DATE: December 06, 2024
EXPIRATION DATE: December 06, 2025

This unique educational program aims to help healthcare providers better summarize the importance of specialist evaluation of genetic data to establish a diagnosis of developmental and epileptic encephalopathies (DEEs), assess clinical data with treatments indicated for the specialized care of patients with DEE based on efficacy and safety outcomes including nonseizure outcomes, and recognize the role of the specialist in leading multidisciplinary teams to optimize transitions of care.

RELEASED DATE: January 15, 2025
EXPIRATION DATE: January 15, 2026

This online learning experience is aimed at guiding participants through the ICSD-3-TR diagnostic criteria for idiopathic hypersomnia, introducing techniques for early assessment and evaluation of IH, and highlighting the significant burdens of idiopathic hypersomnia, including its symptoms and their profound impact on patients' quality of life. A key focus will be on the cardiovascular morbidities associated with excessive daytime sleepiness. The program will also explore treatment options, including the use of sodium oxybate as treatment for sleep disorders. While the original formulation's sodium content may pose risks for patients with cardiovascular comorbidities, a newer low-sodium oxybate formulation will be discussed, along with other therapeutic options for managing patients with idiopathic hypersomnia.

RELEASED DATE: June 30, 2025
EXPIRATION DATE: June 30, 2026

Developmental and epileptic encephalopathies (DEEs) are seizure disorders that often start in infancy, are often drug-resistant, and are associated with seizures of long duration and major developmental delays or loss of developmental skills entirely. These conditions, while rare, are challenging to diagnose and effectively treat. In this CME program, we will address gaps in the prompt diagnosis and management of specific forms of DEEs, provide tips for adequate diagnostic assessment of DEEs and strategies to improve diagnostic work-up, and describe strategies to enhance transitions of care for patients with DEEs.

RELEASED DATE: June 30, 2025
EXPIRATION DATE: June 30, 2026

This three-track educational program is designed to provide clinicians with knowledge and skills to address both immediate and long-term challenges in managing patients with developmental and epileptic encephalopathies (DEEs). Through a case-based approach, the program emphasizes accurate differentiation of DEE conditions based on clinical presentation, diagnostic assessment, imaging, and genetic evaluation. It also covers evidence-based treatment selection guided by established treatment algorithms and expert consensus, effective transitions from pediatric to adult care, and shared decision-making strategies to improve seizure outcomes for patients with DEEs.

RELEASED DATE: July 17, 2025
EXPIRATION DATE: July 17, 2026

This Clinical Minutes program aims to help HCPs increase their ability to: recognize patients with suspected IH or narcolepsy; provide an IH or narcolepsy differential diagnosis; develop personalized treatment plans for patients with IH and narcolepsy; and collaborate with patients and other members of the IH and narcolepsy MDT in the development and implementation of a personalized treatment plan.

RELEASED DATE: September 30, 2025
EXPIRATION DATE: September 30, 2026